. Author manuscript; available in PMC: 2015 Feb 1.

Published in final edited form as: Pharmacotherapy. 2013 Oct 9;34(2):123–130. doi: 10.1002/phar.1355

Table 1.

Baseline characteristics of Caucasian participants in PEAR.

Characteristics^*	Atenolol	HCTZ
Characteristics^*	(n = 232)	(n = 224)
Age (mean ± SD)	49.6 ± 9.5	50.1 ± 9.4
Female gender (n, %)	109 (47.0%)	91 (40.6%)
BMI (kg/m²)	30.3 ± 5.6	30.3 ± 4.9
Waist circumference (cm)	97.6 ± 12.7	98.9 ± 13.6
Glucose (mg/dL)	92.0 ± 11.6	92.9 ± 12.3
Insulin (uU/mL)	10.0 ± 9.9	9.4 ± 8.7
HOMA-IR	2.4 ± 2.8	2.3 ± 2.7
HDL (mg/dL)	46.7 ± 12.4	48.5 ± 13.9
LDL (mg/dL)	121.7 ± 29.4	119.7 ± 29.0
Total cholesterol (mg/dL)	196.2 ± 34.4	197.5 ± 34.6
Triglyceride (mg/dL)	142.7.0 ± 91.8	150.2 ± 101.7
Systolic blood pressure (mmHg)	145.0 ± 9.4	146.1 ± 9.9
Diastolic blood pressure (mmHg)	92.9 ± 5.5	93.6 ± 5.5

Numeric characteristics were presented as mean± standard deviation and categorical variables were presented as number and percentages.

Abbreviation: SD: Standard deviation; HCTZ: hydrochlorothiazide; BMI: body mass index. HOMA-IR: homeostatic model assessment-insulin resistance. HDL: high-density lipoprotein. LDL: low-density lipoprotein.